Summary
Apolipoprotein E (Apo E) epsilon 4 allele is a risk factor for early and late onset Alzheimer’s disease. This prompted us to examine other neurophyschiatric phenotypes. Epsilon 4 allele was significantly enriched in Lewy body dementia (N = 39) but not in Parkinson’s disease (n = 50) or Schizophrenia (n = 175) compared to aged non-demented controls (n = 47) and the Scottish population (n = 400). We conclude that Lewy body disease should be regarded as a variant of Alzheimer’s but not Parkinson’s disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Byrne EJ, Lennox G, Lowe J, et al. (1989) Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 52: 709–717.
Diedrich JF, Minnigan H, Carp RI, et al. (1991) Neuropathological changes in scrapie and Alzheimer’s disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 65: 4759–4768.
Dickson DW, Crystal H, Mattiace LA, et al. (1989) Diffuse Lewy body disease: light and electron microscopic immunohistochemistry of senile plaques. Acta Neuropathol 78: 572–84.
Goate A, Chartier HM, Mullan M, et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349: 704–706.
Hansen L, Salmon D, Galasko D, et al. (1990) The Lewy body variant of Alzheimer’s disease: a clinical and pathological entity. Neurology 40: 1–8.
Hughes AJ, Daniel SE, Kilford L, et al. (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s’ disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181–184.
Levy-Lahad L, Wijsman EM, Nemens E, et al. (1995) A familial Alzheimer’s disease locus on chromosome 1. Science, 269: 980–997.
Lowe J, McDermott H, Landon M, Mayer RJ, Wilkinson K (1990) Ubiquitin carboxyl terminal hydroxylase (PDP9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161: 153–160.
McKhann G, Drachman D, Folstein M, et al. (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group. Neurology 34: 939–944.
Namba Y, Tomonawa M, Kawasaki H, et al. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeld Jakob disease. Brain Res 541: 163–166.
Roses AD (1995) Apolipoprotein E genotyping in the differential diagnosis, not prediction of Alzheimer’s disease. Ann Neurol 38: 6–14.
Sherrington R, Rogaev EI, Liang Y, et al. (1995) Cloning of a gene bearing missense mutations in early onset familial Alzheimer’s disease. Nature 375: 754–760.
St Clair D, Norman J, Perry R, et al. (1994) Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer’s disease and age-matched controls. Neurosci Lett 176: 45–46.
St Clair D, Rennie M, Slorach. E, et al. (1995) Apolipoprotein E epsilon 4 allele is a risk factor for familial and sporadic presenile Alzheimer’s disease in both home and heterozygote carriers. J Med Gen 32: 642–644.
Strittmatter WJ, Saunders AM, Schmechel D, et al. (1993) Apolipoprotein E: high-avidity binding to ß-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977–1981.
Van Broeckhoven C (1995) The presenilins. Nature Genet 11: 230–232.
Wenham PR, Price WH, Blundell A (1991) Apolipoprotein E genotyping by one stage PCR. Lancet 337: 1158–1159.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag/Wien
About this paper
Cite this paper
St. Clair, D. (1997). Apolipoprotein E gene in Parkinson’s disease, Lewy body dementia and Alzheimer’s disease. In: Daniel, S.E., Cruz-Sánchez, F.F., Lees, A.J. (eds) Dementia in Parkinsonism. Journal of Neural Transmission. Supplementa, vol 51. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6846-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6846-2_13
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82959-2
Online ISBN: 978-3-7091-6846-2
eBook Packages: Springer Book Archive